PHIBRO ANIMAL HEALTH CORP (PAHC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue TTM

0 600M 1.2B 1.8B Q4 '21: 833.4M Q1 '22: 852.8M Q2 '22: 879.4M Q3 '22: 907.3M Q4 '22: 942.3M Q1 '23: 960.1M Q2 '23: 972.1M Q3 '23: 978.1M Q4 '23: 977.9M Q1 '24: 976.7M Q2 '24: 982M Q3 '24: 999.6M Q4 '24: 1B Q1 '25: 1B Q2 '25: 1.1B Q3 '25: 1.2B Q4 '25: 1.3B Q1 '26: 1.4B Q2 '26: 1.5B Q3 '26: 1.5B Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Gross Profit TTM

0 200M 400M 600M Q4 '21: 271.4M Q1 '22: 271.9M Q2 '22: 274.3M Q3 '22: 276.8M Q4 '22: 285.4M Q1 '23: 289.4M Q2 '23: 296.1M Q3 '23: 300M Q4 '23: 298.2M Q1 '24: 297.3M Q2 '24: 298.5M Q3 '24: 302.6M Q4 '24: 313.1M Q1 '25: 328.9M Q2 '25: 352.1M Q3 '25: 377.1M Q4 '25: 399.9M Q1 '26: 436.2M Q2 '26: 467M Q3 '26: 488.1M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating Income TTM

0 70M 140M 210M Q4 '21: 74.9M Q1 '22: 73.8M Q2 '22: 76.2M Q3 '22: 75.3M Q4 '22: 79M Q1 '23: 78.1M Q2 '23: 71.6M Q3 '23: 71M Q4 '23: 71.8M Q1 '24: 57.4M Q2 '24: 57.3M Q3 '24: 58.7M Q4 '24: 53.3M Q1 '25: 71.7M Q2 '25: 81.6M Q3 '25: 95.2M Q4 '25: 110.5M Q1 '26: 144M Q2 '26: 168.8M Q3 '26: 180M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Net Income TTM

0 35M 70M 105M Q4 '21: 54.4M Q1 '22: 48.6M Q2 '22: 53.3M Q3 '22: 58.8M Q4 '22: 49.2M Q1 '23: 46.5M Q2 '23: 36.2M Q3 '23: 28.6M Q4 '23: 32.6M Q1 '24: 20.7M Q2 '24: 14.8M Q3 '24: 13.2M Q4 '24: 2.4M Q1 '25: 17.4M Q2 '25: 19.3M Q3 '25: 31.8M Q4 '25: 48.3M Q1 '26: 67.8M Q2 '26: 92.1M Q3 '26: 95.2M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Cost of Revenue TTM

0 350M 700M 1.1B Q4 '21: 562M Q1 '22: 580.9M Q2 '22: 605M Q3 '22: 630.5M Q4 '22: 656.9M Q1 '23: 670.7M Q2 '23: 676M Q3 '23: 678.1M Q4 '23: 679.7M Q1 '24: 679.4M Q2 '24: 683.5M Q3 '24: 697M Q4 '24: 704.6M Q1 '25: 717.9M Q2 '25: 754M Q3 '25: 813.6M Q4 '25: 896.3M Q1 '26: 963.4M Q2 '26: 997.3M Q3 '26: 1B Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating Cash Flow TTM

-35M 0 35M 70M 105M Q4 '21: 48.3M Q1 '22: 50.4M Q2 '22: 43.6M Q3 '22: 33.1M Q4 '22: 31.6M Q1 '23: 17.1M Q2 '23: -5.5M Q3 '23: -5.4M Q4 '23: 13.3M Q1 '24: 40.2M Q2 '24: 74.3M Q3 '24: 79.4M Q4 '24: 87.6M Q1 '25: 84M Q2 '25: 55.5M Q3 '25: 87.3M Q4 '25: 80.1M Q1 '26: 76.8M Q2 '26: 93.1M Q3 '26: 66.1M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Free Cash Flow TTM

-75M -50M -25M 0 25M 50M 75M Q4 '21: 19M Q1 '22: 21.1M Q2 '22: 13.9M Q3 '22: 897K Q4 '22: -5.4M Q1 '23: -35.6M Q2 '23: -60.4M Q3 '23: -58.1M Q4 '23: -38.5M Q1 '24: 4.1M Q2 '24: 37M Q3 '24: 40.3M Q4 '24: 46.4M Q1 '25: 40.7M Q2 '25: 15.3M Q3 '25: 49.1M Q4 '25: 41.8M Q1 '26: 34.3M Q2 '26: 47.3M Q3 '26: 12.8M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '20: 40.5M Q3 '20: 40.5M Q1 '21: 40.5M Q2 '21: 40.5M Q3 '21: 40.5M Q1 '22: 40.5M Q2 '22: 40.5M Q3 '22: 40.5M Q1 '23: 40.5M Q2 '23: 40.5M Q3 '23: 40.5M Q1 '24: 40.5M Q2 '24: 40.5M Q3 '24: 40.5M Q1 '25: 40.6M Q2 '25: 40.7M Q3 '25: 40.7M Q1 '26: 40.9M Q2 '26: 41M Q3 '26: 41M Q3 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.80 1.60 2.40 Q4 '21: 1.34 Q1 '22: 1.20 Q2 '22: 1.31 Q3 '22: 1.45 Q4 '22: 1.21 Q1 '23: 1.15 Q2 '23: 0.90 Q3 '23: 0.71 Q4 '23: 0.82 Q1 '24: 0.52 Q2 '24: 0.37 Q3 '24: 0.33 Q4 '24: 0.06 Q1 '25: 0.43 Q2 '25: 0.48 Q3 '25: 0.78 Q4 '25: 1.19 Q1 '26: 1.67 Q2 '26: 2.26 Q3 '26: 2.34 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.